This Powerhouse AI Stock Just Became More Valuable Than Broadcom (Briefly) and Meta. Here's Why It's Still an Outstanding Buy.

Taiwan Semiconductor delivered a strong Q1, with revenue up 40.6% year over year, gross margin at 66.2%, and operating margin at 58.1%, while high-performance computing sales rose 20% sequentially and made up 61% of revenue. Management guided Q2 revenue growth of 32% year over year and gross margin of 65.5% to 67.5%, but expects 2% to 3% gross margin dilution in the second half from overseas expansion and another 2% to 3% in 2026 from 2nm ramp-up. The article remains bullish overall on AI demand and TSMC’s long-term growth, despite short-term margin pressure from capex and expansion.

Analysis

TSM’s print reinforces a crucial second-order point: the AI buildout is no longer a pure demand story, it is becoming a capacity-allocation story. When a foundry can simultaneously raise utilization, expand overseas, and still guide to near-term margin compression, that usually means the constraint is not end-demand but advanced-node supply; in that regime, the pricing power accrues disproportionately to the few firms that control bottlenecks, not to downstream model builders. That favors the highest-quality AI silicon names and makes weaker foundry competitors and less-differentiated semiconductor suppliers more vulnerable to being structurally left behind.

The back-half margin dilution matters less as a one-quarter EPS issue than as a signal that the industry is entering a heavier capex phase with a delayed payoff. Historically, that tends to compress valuations for 1-2 quarters before it supports a new earnings leg 2-4 quarters later, especially if utilization stays tight. The market is likely underappreciating that overseas expansion and leading-edge node ramps create a short-term gross margin headwind but raise the barrier to entry and strengthen TSM’s strategic leverage over NVDA, custom ASIC vendors, and hyperscalers.

The contrarian risk is not demand collapse; it is capex discipline. If hyperscalers decide to slow incremental AI spend for even two quarters, TSM’s optimistic growth-through-capex linkage becomes the setup for multiple compression across the whole AI supply chain. The more fragile names are the ones with high forward expectations and lower competitive moats—especially if customers push for pricing concessions once supply loosens. Near term, any disappointment in utilization, mix, or overseas ramp efficiency would likely hit the stock within 1-2 earnings cycles, while the upside case requires sustained AI order visibility into 2026.

Key Decisions for Investors

• Stay long TSM on pullbacks, but size it as a 6-12 month compounder rather than a momentum trade; risk/reward favors owning the bottleneck asset while the market digests 1-2 quarters of margin noise.
• Pair long TSM / short INTC or a basket of weaker semis for 3-6 months: the trade expresses that scale and node leadership will capture the next wave of capex while laggards face margin pressure and slower AI monetization.
• Add NVDA on weakness, not strength, over the next 2-4 weeks: TSM’s commentary implies the upstream supply chain remains tight, which supports dispatch for the best-in-class AI accelerator franchise even if near-term capex headlines are noisy.
• Avoid chasing AVGO on the same thesis into earnings windows; custom silicon is levered to the same AI spend cycle, but the stock is more exposed to any pause in hyperscaler ordering than TSM.
• For tactical hedging, buy 1-2 quarter downside protection on a broad semiconductor ETF against long TSM exposure; this isolates company-specific strength while protecting against a sector de-rating if AI capex sentiment rolls over.